Systems and methods for treating cancer and/or augmenting organ function
Systems, methods and devices for controlled sympathectomy procedures for neuromodulation in the treatment of subjects having neoplastic conditions are disclosed. Systems, methods, and devices for interventionally treating a cancerous tumor and cancer related pain are disclosed.
1. A medical system, comprising:
a microsurgical tool dimensioned for insertion into a lumen with a wall, the lumen being in fluid communication with a target region of a subject, wherein the target region comprises at least one of one or more nerves and one or more lymphatic ducts coupled to at least one of a tumor and a metastatic cell within a body of the subject, the microsurgical tool comprising:
a distal tip configured to interface with the wall of the lumen, the distal tip comprising (i) one or more delivery means configured to apply a block to the target region and (ii) one or more microfingers equipped with a plurality of sensing points, the distal tip having one or more dimensions configured to facilitate placement into the lumen; and
a controller configured:
to deploy the one or more microfingers such that at least a subset of the plurality of sensing points interface with the wall of the lumen;
to retract the one or more microfingers such that at least the subset of the plurality of sensing points drag along the wall of the lumen;
to map electrophysiological information along the wall of the lumen based at least in part on signals recorded by the subset of the plurality of sensing points while the one or more microfingers are retracted; and
to control operation of the one or more delivery means based at least in part on the mapped electrophysiological information.
2. The medical system of claim 1 , wherein each of the plurality of sensing points comprises one or more sensors configured to measure an extent of the block on the target region.
3. The medical system of claim 2 , wherein the controller is configured to control the operation of the one or more delivery means based at least in part on feedback from the one or more sensors characterizing the extent of the block on the target region.
4. The medical system of claim 1 , wherein the plurality of sensing points is configured to sense neural traffic, and wherein mapping the electrophysiological information along the wall of the lumen comprises utilizing the sensed neural traffic to locate the target region.
5. The medical system of claim 1 , wherein the one or more delivery means is configured to apply the block by at least one of:
isolating at least one of the tumor and the metastatic cell within the body; and
altering a growth rate of at least one of the tumor and the metastatic cell.
6. The medical system of claim 1 , wherein the one or more delivery means is configured to apply the block by injecting a neurolytic agent into at least one of the one or more nerves and the one or more lymphatic ducts.
7. The medical system of claim 1 , wherein the one or more delivery means is configured to apply the block by injecting an agent into at least one of the one or more nerves and the one or more lymphatic ducts.
8. The medical system of claim 1 , wherein the one or more delivery means is configured to apply the block to at least one of a nerve and a lymphatic duct at least 10 millimeters (mm) in length.
9. The medical system of claim 1 , wherein the one or more delivery means is configured to apply the block by accessing the target region via guiding the distal tip via one of an artery, a vein and a duct.
10. The medical system of claim 1 , wherein the one or more delivery means is configured to apply the block by altering a structure of a perineural sheath of at least one of the one or more nerves.
11. The medical system of claim 1 , wherein the one or more delivery means is configured to apply the block by performing architectural destruction of at least one of nerve tissue and lymphatic ductal tissue via inflammation.
12. The medical system of claim 1 , wherein the one or more delivery means is configured to apply the block by forming scar tissue along at least one of the one or more nerves and the one or more lymphatic ducts.
13. The medical system of claim 1 , wherein the one or more delivery means is configured to apply the block by applying a single therapeutic compound to the target region.
14. The medical system of claim 13 , wherein the single therapeutic compound comprises one of an ablative agent, a migration limiting agent, and an inflammatory accelerating agent.
15. The medical system of claim 1 , wherein the one or more delivery means is configured to apply the block to at least one of the one or more nerves and the one or more lymphatic ducts traveling along the lumen coupling a first organ to at least a second organ in the body.
16. The medical system of claim 1 , wherein the one or more delivery means is configured to apply the block by applying energy to at least one of the one or more nerves and the one or more lymphatic ducts.
17. The medical system of claim 16 , wherein the energy is at least one of thermal energy, radio frequency current, microwave current, ultrasound, radiation and cryotherapy.
18. The medical system of claim 1 , wherein mapping the electrophysiological information comprises generating an anatomical map of the target region.
19. The medical system of claim 1 , wherein mapping the electrophysiological information comprises evaluating a location of one or more active neuromuscular sites in a vicinity of the target region.
20. The medical system of claim 1 , wherein mapping the electrophysiological information comprises evaluating at least one of a type and a direction of neurological traffic in a vicinity of each of the plurality of sensing points.